Related Experiment Video
Updated: Jul 8, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia
M R Korte1, M J van Heerde, R A de Man
1Department of Nephrology, Erasmus Medical Centre, Rotterdam, the Netherlands.
Abstract:
Mixed-type cryoglobulins are strongly associated with hepatitis C virus (HCV) infection and may lead to vasculitis with renal involvement. The treatment of this condition is antiviral therapy for HCV, but this may be ineffective or not tolerated because of side effects. Alternative strategies such as immunosuppressive drugs and plasmapheresis are of limited use, especially in patients after liver transplantation (LTx). We describe an LTx patient with cryoglobulinaemia-associated glomerulonephritis, who was treated successfully with the B cell depleting monoclonal antibody rituximab.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Rheumatic Heart Disease III: Medical Management
Nephrotic Syndrome II : Assessment and Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Nephrotic Syndrome I : Introduction
